Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2019-04-17 | Mason Brad | CEO | Sell | 3,749 | $52.52 | $196,897.48 | -2.1% | → |
| 2019-02-19 | Bianchi Davide | President, Global Extremities | Sell | 24,400 | $65.00 | $1,586,000.00 | -27.1% | → |
| 2019-01-15 | Mason Brad | CEO | Sell | 5,000 | $50.13 | $250,664.74 | -1.8% | → |
| 2018-11-05 | NIEMANN BRADLEY V. | President of Global Spine | Sell | 387 | $61.63 | $23,850.81 | -1.5% | → |
| 2018-11-02 | FAULSTICK LUKE T | Director | Sale+OE | 8,450 | $61.05 | $515,911.00 | -23.7% | → |
| 2018-11-02 | Elting Kimberley A. | Chief Legal & Admin Officer | Sale+OE | 7,000 | $61.05 | $427,337.40 | -30.8% | → |
| 2018-11-02 | DOUG RICE | CFO | Sell | 6,057 | $61.25 | $371,003.82 | -10.3% | → |
| 2018-10-11 | DOUG RICE | CFO | Sell | 3,949 | $55.65 | $219,753.95 | -10.9% | → |
| 2018-09-05 | Mason Brad | CEO | Sell | 2,500 | $53.02 | $132,554.50 | -1.7% | → |
| 2018-08-07 | Mason Brad | CEO | Sell | 2,500 | $53.27 | $133,168.05 | -0.4% | → |
| 2018-07-10 | Mason Brad | CEO | Sell | 2,500 | $58.62 | $146,553.75 | -1.8% | → |
| 2018-07-03 | NIEMANN BRADLEY V. | President of Global Spine | Sale+OE | 11,250 | $57.02 | $641,435.17 | -16.7% | → |
| 2018-06-20 | FUJIKAWA RAYMOND | President Spine Fixation | Sale+OE | 32,243 | $60.21 | $1,941,202.05 | -51.9% | → |
| 2018-06-19 | Bianchi Davide | President Extremity Fixation | Sell | 14,762 | $60.00 | $885,720.00 | -26.4% | → |
| 2018-06-18 | Finegan Michael | Chief Strategy Officer | Sale+OE | 30,000 | $58.81 | $1,764,300.77 | -26.2% | → |
| 2018-06-14 | Mason Brad | CEO | Sell | 2,500 | $57.95 | $144,863.50 | -1.7% | → |
| 2018-05-03 | MATRICARIA RONALD A | Director | Buy | 10,000 | $51.97 | $519,724.00 | +10.9% | → |
| 2017-12-11 | NIEMANN BRADLEY V. | President Biostim | Sell | 5,547 | $52.08 | $288,860.58 | -13.8% | → |
| 2017-11-28 | Mason Brad | CEO | Sell | 5,000 | $53.48 | $267,400.00 | -2.7% | → |
| 2017-11-06 | FAULSTICK LUKE T | Director | Sell | 4,800 | $51.22 | $245,845.92 | -38.3% | → |
| 2017-09-11 | NIEMANN BRADLEY V. | President Biostim | Sell | 6,956 | $49.44 | $343,926.20 | -14.8% | → |
| 2017-09-11 | DOUG RICE | CFO | Sell | 7,353 | $49.46 | $363,688.94 | -14.1% | → |
| 2017-08-21 | Mason Brad | CEO | Sell | 2,733 | $48.10 | $131,457.30 | -1.4% | → |
| 2017-08-10 | FUJIKAWA RAYMOND | President Spine Fixation | Sell | 6,364 | $47.06 | $299,501.93 | -17.0% | → |
| 2016-11-10 | Mason Brad | CEO | Sell | 9,538 | $36.83 | $351,266.94 | -3.1% | → |
| 2016-09-01 | Finegan Michael | Chief Strategy Officer | Sale+OE | 25,000 | $45.16 | $1,129,000.00 | -37.5% | → |
| 2016-06-10 | Sainz Maria | Director | Sell | 4,157 | $46.33 | $192,589.65 | -16.6% | → |
| 2016-06-09 | Mason Brad | CEO | Sale+OE | 18,336 | $46.00 | $843,456.00 | -11.4% | → |
| 2016-06-08 | NIEMANN BRADLEY V. | President Biostim | Sell | 3,402 | $44.70 | $152,069.40 | -11.8% | → |
| 2016-05-20 | GOODWIN ROBERT ALLEN II | President Biologics | Sale+OE | 13,187 | $44.00 | $580,228.00 | -32.1% | → |
| 2016-04-18 | Finegan Michael | Chief Strategy Officer | Sale+OE | 80,972 | $42.71 | $3,458,324.00 | -51.1% | → |
| 2015-11-11 | Finegan Michael | Chief Strategy Officer | Sell | 14,140 | $42.00 | $593,880.00 | -19.5% | → |
| 2015-11-06 | Schumm Jeffrey | Chief Administrative Officer | Sell | 15,000 | $40.67 | $610,022.04 | -9.1% | → |
| 2015-11-06 | Mason Brad | CEO | Sell | 15,018 | $40.60 | $609,779.12 | -5.0% | → |